on Evotec AG (NASDAQ:EVTCY)
Evotec SE to Release Q3 2025 Financial Results on November 5th
Evotec SE, a leading life sciences firm, announced the release of its financial results for the first nine months of 2025 scheduled for November 5, 2025. The company, listed on the Frankfurt Stock Exchange and NASDAQ, will host a conference call discussing the results and presenting performance updates.
The call, conducted in English, will occur at 2:00 pm CET. Interested parties can join via an audio webcast, with presentation slides available online. Pre-registration is required, providing attendees with necessary dial-in details.
The forthcoming announcement and webcast aim to offer insights into Evotec's financial and operational progress, reflecting its focus on innovation in drug discovery. The expert team of over 4,800 operates globally, contributing to key therapeutic areas.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Evotec AG news